Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,510 USD | -1,31% | -0,12% | +8,25% |
13/09 | RTW Biotech's halfjaarlijkse nettovermogenswaarde stijgt ondanks "uitdagende markten". | AN |
13/09 | RTW Biotech Opportunities' H1 Netto Beleggingsverlies Vergroot | MT |
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement (Y) | Dividendrendement (Y+1) | K/w-verhouding | Koers-boekwaarde | EV/omzet | Beurskap. / EBITDA | Beurskap. / EBIT | Kapi. ($) | |
---|---|---|---|---|---|---|---|---|---|
+9.44% | +9.55% | 8.27x | 1,025 | 8.67x | - | - | 12,82 mld. | ||
+1.25% | +1.29% | 9.92x | 0,6606 | - | - | 9.28x | 8,57 mld. | ||
+14.65% | +13.41% | 8.41x | 0,8286 | 7.6x | - | - | 5,54 mld. | ||
+3.73% | +3.96% | - | - | - | - | 9.4x | 4,15 mld. | ||
+6.59% | +6.65% | 15.34x | 1,649 | 13.56x | - | 16.14x | 3,96 mld. | ||
+6.26% | +6.34% | 10.54x | 0,8081 | 9.62x | 11.45x | 11.45x | 3,51 mld. | ||
+7.21% | +7.32% | 17.6x | 0,8201 | 16.6x | 24.32x | 14.36x | 3,39 mld. | ||
Gemiddelde | +7,02% | +6,93% | 11,68x | 0,97 | 11,21x | 17,89x | 12,13x | 5,99 mld. | |
Gewogen gemiddelde per kap. | +7,18% | +7,09% | 10,45x | 0,94 | 10,16x | 17,77x | 11,51x |
- Beurs
- Aandelen
- Koers RTWG
- Sector RTW Biotech Opportunities Ltd
- Sectorale dividenden